HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcos Tatagiba Selected Research

Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)

4/2022Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcos Tatagiba Research Topics

Disease

44Neoplasms (Cancer)
08/2022 - 06/2002
19Glioma (Gliomas)
01/2022 - 08/2005
15Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2005
15Acoustic Neuroma (Acoustic Neurinoma)
06/2021 - 02/2007
13Meningioma (Meningiomas)
08/2022 - 01/2006
7Neurofibromatosis 2 (Neurofibromatosis Type II)
08/2022 - 01/2002
7Astrocytoma (Pilocytic Astrocytoma)
04/2022 - 07/2011
6Brain Neoplasms (Brain Tumor)
04/2022 - 08/2005
5Neurilemmoma (Schwannoma)
01/2021 - 01/2006
5Cysts
03/2020 - 11/2005
5Neoplasm Metastasis (Metastasis)
01/2019 - 09/2002
4Air Embolism (Gas Embolism)
01/2022 - 03/2008
4Hydrocephalus (Hydrocephaly)
03/2020 - 05/2005
3Pain (Aches)
09/2022 - 03/2015
3Oligodendroglioma
01/2022 - 07/2011
3Pituitary Neoplasms (Pituitary Adenoma)
11/2021 - 01/2018
3Infections
01/2016 - 04/2007
3Moyamoya Disease (Moya-Moya Disease)
03/2011 - 12/2010
2Neuroepithelial Neoplasms (Gliomatosis Cerebri)
04/2022 - 08/2012
2Infarction (Infarctions)
04/2022 - 12/2020
2AIDS-Related Complex (ARC)
01/2022 - 10/2021
2Residual Neoplasm
10/2020 - 07/2019
2Melanoma (Melanoma, Malignant)
01/2019 - 06/2016
2Testicular Neoplasms (Testicular Cancer)
01/2019 - 11/2018
2Aneurysm (Aneurysms)
08/2015 - 12/2010
2Wounds and Injuries (Trauma)
03/2014 - 03/2002
2Seizures (Absence Seizure)
02/2012 - 08/2005
2Granuloma
03/2007 - 01/2006
1Facial Paralysis (Facial Palsy)
01/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2021
1Epilepsy (Aura)
04/2021
1Tinnitus
01/2021
1Tremor (Tremors)
12/2020
1Pneumocephalus
11/2020
1Cough
03/2020

Drug/Important Bio-Agent (IBA)

9Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 - 07/2011
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
4somatostatin receptor 2IBA
08/2022 - 01/2018
4ParaffinIBA
07/2022 - 03/2013
4Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2011
4Nimodipine (Modus)FDA LinkGeneric
06/2021 - 03/2016
4Biological ProductsIBA
05/2020 - 01/2008
3somatostatin receptor type 1IBA
08/2022 - 01/2018
3AntibodiesIBA
05/2021 - 03/2013
3Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 07/2010
3MethyltransferasesIBA
01/2021 - 08/2012
3Bevacizumab (Avastin)FDA Link
10/2020 - 11/2019
3Neoplasm Antigens (Tumor Antigens)IBA
06/2019 - 11/2018
3Peptides (Polypeptides)IBA
03/2019 - 11/2018
3Capsules (Microcapsules)IBA
02/2014 - 11/2005
3hypericinIBA
07/2008 - 12/2005
2Pharmaceutical PreparationsIBA
09/2022 - 02/2012
2Somatostatin Receptors (Somatostatin Receptor)IBA
08/2022 - 01/2018
2Phosphotransferases (Kinase)IBA
04/2022 - 01/2020
2Acetazolamide (Diamox)FDA LinkGeneric
04/2022 - 12/2020
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2021 - 11/2019
2GadoliniumIBA
12/2020 - 07/2009
2ProteomeIBA
01/2019 - 11/2018
2AntigensIBA
01/2019 - 11/2018
2Starch (Cornstarch)IBA
12/2017 - 03/2016
2N 30IBA
12/2017 - 07/2011
2AcidsIBA
08/2016 - 09/2015
2Matrix Metalloproteinases (MMPs)IBA
08/2012 - 02/2012
2Proteins (Proteins, Gene)FDA Link
02/2012 - 04/2007
2Anticonvulsants (Antiepileptic Drugs)IBA
02/2012 - 08/2005
2Photosensitizing Agents (Photosensitizers)IBA
07/2008 - 12/2005
1Monophenol Monooxygenase (Tyrosinase)IBA
04/2022
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
04/2022
12,6-dinitrotoluene (DNT)IBA
04/2022
1Radioisotopes (Radionuclides)IBA
02/2022
1alpha-hydroxyglutarateIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1APTIBA
11/2021
1O-(6)-methylguanineIBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Histones (Histone)IBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1Complement System Proteins (Complement)IBA
12/2020
1Irinotecan (Camptosar)FDA LinkGeneric
03/2020

Therapy/Procedure

12Radiotherapy
02/2022 - 06/2002
10Therapeutics
01/2020 - 05/2005
6Decompression
01/2022 - 03/2002
6Drug Therapy (Chemotherapy)
01/2021 - 08/2005
5Neurosurgical Procedures
01/2022 - 05/2007
5Endoscopes
12/2018 - 12/2010
5Craniotomy
06/2013 - 07/2006
4Adjuvant Radiotherapy
08/2022 - 11/2019
3Laminectomy
10/2021 - 01/2012
3Immunotherapy
01/2019 - 11/2018
3Photochemotherapy (Photodynamic Therapy)
07/2008 - 12/2005
2Electrodes (Electrode)
04/2021 - 04/2008
2Lasers (Laser)
03/2021 - 01/2012
2Patient Positioning
05/2019 - 02/2007
1Psychology Biofeedback (Biofeedback)
01/2022
1Physical Therapy Modalities (Physical Therapy Technique)
01/2022
1Investigational Therapies (Experimental Therapy)
01/2021
1Transcranial Magnetic Stimulation
01/2021
1Deep Brain Stimulation
12/2020
1Contraindications
11/2020
1Colonic Pouches (S Pouch)
03/2020